TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Genor Biopharma Holdings Limited ( (HK:6998) ) is now available.
Genor Biopharma Holdings Limited announced a series of strategic transactions, including a proposed merger, reverse takeover, and changes in company structure. These initiatives aim to enhance the company’s market presence and operational capabilities. The proposed merger and new listing application are subject to regulatory approvals, and the company is actively working with professional parties to address regulatory comments. Shareholders are advised to exercise caution as the merger’s completion is contingent on several conditions, including the approval of a whitewash waiver.
More about Genor Biopharma Holdings Limited
Genor Biopharma Holdings Limited is a biopharmaceutical company incorporated in the Cayman Islands, focusing on developing and commercializing innovative drugs. The company is listed on the Hong Kong Stock Exchange and is involved in substantial acquisitions and mergers to strengthen its market position.
Average Trading Volume: 1,034,547
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.44B
See more data about 6998 stock on TipRanks’ Stock Analysis page.